PRRT2 and Hyperglycemia: In particular, the increase of metabolites associated with hyperglycemia in microvessel cells can cause specific functional and structural changes mediated by PKC or ROS activation and exacerbated by the accumulation of non-diabetes-specific toxic substances, such as oxidants, AGE, and methylglyoxal.